Results 111 to 120 of about 8,614 (172)

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade. [PDF]

open access: yesJ Natl Cancer Inst, 2020
Prat A   +35 more
europepmc   +1 more source

Histology-informed microstructural diffusion simulations for MRI cancer characterisation-the Histo-μSim framework. [PDF]

open access: yesCommun Biol
Grigoriou A   +24 more
europepmc   +1 more source

Simulation-Informed Evaluation of Microvascular Parameter Mapping for Diffusion MR Imaging of Solid Tumours. [PDF]

open access: yesMagn Reson Med
Voronova AK   +11 more
europepmc   +1 more source

Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors. [PDF]

open access: yesESMO Open, 2022
Borazanci E   +22 more
europepmc   +1 more source

La implantación del Banco Bilbao Vizcaya Argentaria (BBVA) en América Latina

open access: yes
Este artículo trata la evolución de la implantación del Banco Bilbao Vizcaya Argentaria (BBVA) en América Latina. El proceso de expansión se remonta a los inicios de los llamados “bancos históricos” -Banco de Bilbao, Banco de Vizcaya y Banco Exterior de España-, antecesores del actual grupo BBVA.
openaire   +1 more source

Pervasive and recurrent hybridization prevents inbreeding in Europe's most threatened seabird. [PDF]

open access: yesProc Natl Acad Sci U S A
Izquierdo-Arànega G   +9 more
europepmc   +1 more source

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study. [PDF]

open access: yesAnn Oncol, 2019
Guarneri V   +17 more
europepmc   +1 more source

Mixed convolutional and long short-term memory network for the detection of lethal ventricular arrhythmia. [PDF]

open access: yesPLoS One, 2019
Picon A   +10 more
europepmc   +1 more source

Emotion Forecasting: A Transformer-Based Approach. [PDF]

open access: yesJ Med Internet Res
Paz-Arbaizar L   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy